Selected research
Industry Growth & Trends
Global Chitosan-based Hemostatic Gauze Industry Growth and Trends Forecast to 2032
Market perspective
The global Chitosan-based Hemostatic Gauze market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Chitosan-based Hemostatic Gauze is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Chitosan-based Hemostatic Gauze is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Chitosan-based Hemostatic Gauze is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Chitosan-based Hemostatic Gauze include Advamedica, Anscare, BioPharm Med, Hemoflex, MedTrade Products, Mermaid Medical, Tricol Biomedical, Biotemed and Shijiazhuang Yishengtang Medical Product, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Chitosan-based Hemostatic Gauze market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Chitosan-based Hemostatic Gauze market size, estimates, and forecasts are presented in terms of sales volume (Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Chitosan-based Hemostatic Gauze market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Chitosan-based Hemostatic Gauze.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Chitosan-based Hemostatic Gauze market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Chitosan-based Hemostatic Gauze Market by Company
Advamedica
Anscare
BioPharm Med
Hemoflex
MedTrade Products
Mermaid Medical
Tricol Biomedical
Biotemed
Shijiazhuang Yishengtang Medical Product
Chitosan-based Hemostatic Gauze Segment by Type
Z-shaped Folded Hemostatic Gauze
Non-folded Hemostatic Gauze
Chitosan-based Hemostatic Gauze Segment by Application
Surgery
First Aid
Chitosan-based Hemostatic Gauze Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Chitosan-based Hemostatic Gauze market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Chitosan-based Hemostatic Gauze and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Chitosan-based Hemostatic Gauze.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Chitosan-based Hemostatic Gauze manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Chitosan-based Hemostatic Gauze in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Z-shaped Folded Hemostatic Gauze
- Non-folded Hemostatic Gauze
Applications
- Surgery
- First Aid
Companies covered
- Advamedica
- Anscare
- BioPharm Med
- Hemoflex
- MedTrade Products
- Mermaid Medical
- Tricol Biomedical
- Biotemed
- Shijiazhuang Yishengtang Medical Product
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Chitosan-based Hemostatic Gauze Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Chitosan-based Hemostatic Gauze Sales Estimates and Forecasts (2021-2032)
- 1.3 Chitosan-based Hemostatic Gauze Market by Type
- 1.3.1 Z-shaped Folded Hemostatic Gauze
- 1.3.2 Non-folded Hemostatic Gauze
- 1.4 Global Chitosan-based Hemostatic Gauze Market Size by Type
- 1.4.1 Global Chitosan-based Hemostatic Gauze Market Size Overview by Type (2021-2032)
- 1.4.2 Global Chitosan-based Hemostatic Gauze Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Chitosan-based Hemostatic Gauze Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Chitosan-based Hemostatic Gauze Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Chitosan-based Hemostatic Gauze Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Chitosan-based Hemostatic Gauze Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Chitosan-based Hemostatic Gauze Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Chitosan-based Hemostatic Gauze Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Chitosan-based Hemostatic Gauze Industry Trends
- 2.2 Chitosan-based Hemostatic Gauze Industry Drivers
- 2.3 Chitosan-based Hemostatic Gauze Industry Opportunities and Challenges
- 2.4 Chitosan-based Hemostatic Gauze Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Chitosan-based Hemostatic Gauze Revenue (2021-2026)
- 3.2 Global Top Players by Chitosan-based Hemostatic Gauze Sales (2021-2026)
- 3.3 Global Top Players by Chitosan-based Hemostatic Gauze Price (2021-2026)
- 3.4 Global Chitosan-based Hemostatic Gauze Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Chitosan-based Hemostatic Gauze Major Company Production Sites & Headquarters
- 3.6 Global Chitosan-based Hemostatic Gauze Company, Product Type & Application
- 3.7 Global Chitosan-based Hemostatic Gauze Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Chitosan-based Hemostatic Gauze Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Chitosan-based Hemostatic Gauze Players Market Share by Revenue in 2025
- 3.8.3 2025 Chitosan-based Hemostatic Gauze Tier 1, Tier 2, and Tier 3
4 Chitosan-based Hemostatic Gauze Regional Status and Outlook
- 4.1 Global Chitosan-based Hemostatic Gauze Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Chitosan-based Hemostatic Gauze Historic Market Size by Region
- 4.2.1 Global Chitosan-based Hemostatic Gauze Sales in Volume by Region (2021-2026)
- 4.2.2 Global Chitosan-based Hemostatic Gauze Sales in Value by Region (2021-2026)
- 4.2.3 Global Chitosan-based Hemostatic Gauze Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Chitosan-based Hemostatic Gauze Forecasted Market Size by Region
- 4.3.1 Global Chitosan-based Hemostatic Gauze Sales in Volume by Region (2027-2032)
- 4.3.2 Global Chitosan-based Hemostatic Gauze Sales in Value by Region (2027-2032)
- 4.3.3 Global Chitosan-based Hemostatic Gauze Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Chitosan-based Hemostatic Gauze by Application
- 5.1 Chitosan-based Hemostatic Gauze Market by Application
- 5.1.1 Surgery
- 5.1.2 First Aid
- 5.2 Global Chitosan-based Hemostatic Gauze Market Size by Application
- 5.2.1 Global Chitosan-based Hemostatic Gauze Market Size Overview by Application (2021-2032)
- 5.2.2 Global Chitosan-based Hemostatic Gauze Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Chitosan-based Hemostatic Gauze Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Chitosan-based Hemostatic Gauze Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Chitosan-based Hemostatic Gauze Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Chitosan-based Hemostatic Gauze Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Chitosan-based Hemostatic Gauze Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Chitosan-based Hemostatic Gauze Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Advamedica
- 6.1.1 Advamedica Company Information
- 6.1.2 Advamedica Business Overview
- 6.1.3 Advamedica Chitosan-based Hemostatic Gauze Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Advamedica Chitosan-based Hemostatic Gauze Product Portfolio
- 6.1.5 Advamedica Recent Developments
- 6.2 Anscare
- 6.2.1 Anscare Company Information
- 6.2.2 Anscare Business Overview
- 6.2.3 Anscare Chitosan-based Hemostatic Gauze Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Anscare Chitosan-based Hemostatic Gauze Product Portfolio
- 6.2.5 Anscare Recent Developments
- 6.3 BioPharm Med
- 6.3.1 BioPharm Med Company Information
- 6.3.2 BioPharm Med Business Overview
- 6.3.3 BioPharm Med Chitosan-based Hemostatic Gauze Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 BioPharm Med Chitosan-based Hemostatic Gauze Product Portfolio
- 6.3.5 BioPharm Med Recent Developments
- 6.4 Hemoflex
- 6.4.1 Hemoflex Company Information
- 6.4.2 Hemoflex Business Overview
- 6.4.3 Hemoflex Chitosan-based Hemostatic Gauze Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Hemoflex Chitosan-based Hemostatic Gauze Product Portfolio
- 6.4.5 Hemoflex Recent Developments
- 6.5 MedTrade Products
- 6.5.1 MedTrade Products Company Information
- 6.5.2 MedTrade Products Business Overview
- 6.5.3 MedTrade Products Chitosan-based Hemostatic Gauze Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 MedTrade Products Chitosan-based Hemostatic Gauze Product Portfolio
- 6.5.5 MedTrade Products Recent Developments
- 6.6 Mermaid Medical
- 6.6.1 Mermaid Medical Company Information
- 6.6.2 Mermaid Medical Business Overview
- 6.6.3 Mermaid Medical Chitosan-based Hemostatic Gauze Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Mermaid Medical Chitosan-based Hemostatic Gauze Product Portfolio
- 6.6.5 Mermaid Medical Recent Developments
- 6.7 Tricol Biomedical
- 6.7.1 Tricol Biomedical Company Information
- 6.7.2 Tricol Biomedical Business Overview
- 6.7.3 Tricol Biomedical Chitosan-based Hemostatic Gauze Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Tricol Biomedical Chitosan-based Hemostatic Gauze Product Portfolio
- 6.7.5 Tricol Biomedical Recent Developments
- 6.8 Biotemed
- 6.8.1 Biotemed Company Information
- 6.8.2 Biotemed Business Overview
- 6.8.3 Biotemed Chitosan-based Hemostatic Gauze Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Biotemed Chitosan-based Hemostatic Gauze Product Portfolio
- 6.8.5 Biotemed Recent Developments
- 6.9 Shijiazhuang Yishengtang Medical Product
- 6.9.1 Shijiazhuang Yishengtang Medical Product Company Information
- 6.9.2 Shijiazhuang Yishengtang Medical Product Business Overview
- 6.9.3 Shijiazhuang Yishengtang Medical Product Chitosan-based Hemostatic Gauze Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 Shijiazhuang Yishengtang Medical Product Chitosan-based Hemostatic Gauze Product Portfolio
- 6.9.5 Shijiazhuang Yishengtang Medical Product Recent Developments
7 North America by Country
- 7.1 North America Chitosan-based Hemostatic Gauze Sales by Country
- 7.1.1 North America Chitosan-based Hemostatic Gauze Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Chitosan-based Hemostatic Gauze Sales by Country (2021-2026)
- 7.1.3 North America Chitosan-based Hemostatic Gauze Sales Forecast by Country (2027-2032)
- 7.2 North America Chitosan-based Hemostatic Gauze Market Size by Country
- 7.2.1 North America Chitosan-based Hemostatic Gauze Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Chitosan-based Hemostatic Gauze Market Size by Country (2021-2026)
- 7.2.3 North America Chitosan-based Hemostatic Gauze Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Chitosan-based Hemostatic Gauze Sales by Country
- 8.1.1 Europe Chitosan-based Hemostatic Gauze Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Chitosan-based Hemostatic Gauze Sales by Country (2021-2026)
- 8.1.3 Europe Chitosan-based Hemostatic Gauze Sales Forecast by Country (2027-2032)
- 8.2 Europe Chitosan-based Hemostatic Gauze Market Size by Country
- 8.2.1 Europe Chitosan-based Hemostatic Gauze Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Chitosan-based Hemostatic Gauze Market Size by Country (2021-2026)
- 8.2.3 Europe Chitosan-based Hemostatic Gauze Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Chitosan-based Hemostatic Gauze Sales by Country
- 9.1.1 Asia-Pacific Chitosan-based Hemostatic Gauze Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Chitosan-based Hemostatic Gauze Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Chitosan-based Hemostatic Gauze Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Chitosan-based Hemostatic Gauze Market Size by Country
- 9.2.1 Asia-Pacific Chitosan-based Hemostatic Gauze Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Chitosan-based Hemostatic Gauze Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Chitosan-based Hemostatic Gauze Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Chitosan-based Hemostatic Gauze Sales by Country
- 10.1.1 South America Chitosan-based Hemostatic Gauze Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Chitosan-based Hemostatic Gauze Sales by Country (2021-2026)
- 10.1.3 South America Chitosan-based Hemostatic Gauze Sales Forecast by Country (2027-2032)
- 10.2 South America Chitosan-based Hemostatic Gauze Market Size by Country
- 10.2.1 South America Chitosan-based Hemostatic Gauze Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Chitosan-based Hemostatic Gauze Market Size by Country (2021-2026)
- 10.2.3 South America Chitosan-based Hemostatic Gauze Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Chitosan-based Hemostatic Gauze Sales by Country
- 11.1.1 Middle East and Africa Chitosan-based Hemostatic Gauze Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Chitosan-based Hemostatic Gauze Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Chitosan-based Hemostatic Gauze Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Chitosan-based Hemostatic Gauze Market Size by Country
- 11.2.1 Middle East and Africa Chitosan-based Hemostatic Gauze Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Chitosan-based Hemostatic Gauze Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Chitosan-based Hemostatic Gauze Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Chitosan-based Hemostatic Gauze Value Chain Analysis
- 12.1.1 Chitosan-based Hemostatic Gauze Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Chitosan-based Hemostatic Gauze Production Mode & Process
- 12.2 Chitosan-based Hemostatic Gauze Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Chitosan-based Hemostatic Gauze Distributors
- 12.2.3 Chitosan-based Hemostatic Gauze Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst